Coates Philip J, Lorimore Sally A, Wright Eric G
Cancer Biology and Clinical Pathology Unit, Division of Pathology and Neurosciences, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
J Pathol. 2005 Jan;205(2):221-35. doi: 10.1002/path.1701.
Cancers arise as a consequence of the accumulation of multiple genetic mutations in a susceptible cell, resulting in perturbation of regulatory networks that control proliferation, survival, and cellular function. Here, the sources of cellular stress that can cause oncogenic mutations and the responses of cells to DNA damage are reviewed. The role of different repair pathways and the potential for cell- and tissue-specific reliance on individual repair mechanisms are discussed. Evidence for cell- and tissue-specific activation of p53-mediated growth arrest and apoptosis after exposure to an individual genotoxin is assessed and some of the potential mediators of these different responses are provided. These cell- and tissue-specific responses to particular forms of DNA damage are likely to be key determinants of tissue-specific tumour susceptibility, and there is good evidence for genetic variations in these responses. The role that genotoxic agents play in altering the microenvironment to produce indirect effects on tumourigenesis through altered production of free radicals and cytokines that are characteristic of inflammatory-type processes is also evaluated. Changes to the microenvironment as direct or indirect effects of genotoxic stress can be involved in both tumour initiation and progression and may even be a prerequisite for tumourigenesis. Therefore, tumour susceptibility after endogenous or exogenous genotoxic stress represents a balance between cell-intrinsic responses of target cells and changes to the microenvironment. A fuller understanding of cell- and tissue-specific responses, alterations to the microenvironment, and genetic modifiers of these responses could lead to novel prevention and therapeutic strategies for common forms of human malignancy.
癌症的发生是由于易感细胞中多个基因突变的积累,导致控制细胞增殖、存活和细胞功能的调控网络受到干扰。本文综述了可导致致癌突变的细胞应激源以及细胞对DNA损伤的反应。讨论了不同修复途径的作用以及细胞和组织对个体修复机制的特异性依赖潜力。评估了暴露于单一基因毒素后p53介导的生长停滞和凋亡在细胞和组织中的特异性激活证据,并提供了这些不同反应的一些潜在介质。这些对特定形式DNA损伤的细胞和组织特异性反应可能是组织特异性肿瘤易感性的关键决定因素,并且有充分证据表明这些反应存在基因变异。还评估了遗传毒性剂通过改变自由基和细胞因子的产生对肿瘤发生产生间接影响的作用,这些自由基和细胞因子是炎症型过程的特征。遗传毒性应激的直接或间接影响导致的微环境变化可能参与肿瘤的起始和进展,甚至可能是肿瘤发生的先决条件。因此,内源性或外源性遗传毒性应激后的肿瘤易感性代表了靶细胞的细胞内在反应与微环境变化之间的平衡。对细胞和组织特异性反应、微环境改变以及这些反应的遗传修饰因子的更全面理解可能会为常见人类恶性肿瘤带来新的预防和治疗策略。